Taimour Langaee

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

Charles Eby, JA Johnson, Elena Deych et al. · Clinical Pharmacology & Therapeutics · 2008 · 834 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

CYP4F2 genetic variant alters required warfarin dose

Michael D. Caldwell, Tarif Awad, Julie A. Johnson et al. · Blood · 2008 · 522 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

Gregory M. Cooper, Julie A. Johnson, Taimour Langaee et al. · Blood · 2008 · 486 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

Minoli A. Perera, Larisa H. Cavallari, Nita A. Limdi et al. · The Lancet · 2013 · 276 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements

Christina L. Aquilante, Taimour Langaee, Lucy E. Correa-López et al. · Clinical Pharmacology & Therapeutics · 2006 · 270 citations

Medicine, Genetics, Pharmacology +14